KDventures portfolio company Modus Therapeutics raises SEK 7.6 million in private placement

• KDventures said portfolio company Modus Therapeutics completed a private placement raising SEK 7.6 million to fund sevuparin development plans for 2027.
• The unregistered share sale comprised 20,000,000 new shares priced at SEK 0.38 each, before transaction costs.
• Proceeds target manufacturing for future activities, business development, and a severe-malaria research collaboration.
• KDventures’ stake in Modus Therapeutics fell to 51% following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KDventures AB published the original content used to generate this news brief on September 04, 2026, and is solely responsible for the information contained therein.